Neobiosis Appoints Pascal Goldschmidt, M.D. as Chief Medical Officer

UF Innovate | Sid Martin Biotech resident Neobiosis, a clinical-stage contract development and manufacturing organization, managed by scientists and physicians and focused on the science of regenerative medicine, announced the appointment of Pascal Goldschmidt, M.D. as Chief Medical Officer.

AGTC Breaks Ground on New Biotech Lab in Alachua

Applied Genetic Technologies Corporation will build a new 21,000 square foot laboratory facility in Alachua. The facility will include control labs and a manufacturing suite and will add 50 jobs.

AGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product Candidates

UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has initiated plans to lease a build-to-suit 21,000 square foot current Good Manufacturing Practices (cGMP) manufacturing and quality control facility adjacent to its Florida facility to prepare for anticipated late-stage development of its X-Linked Retinitis Pigmentosa (XLRP) and Achromatopsia (ACHM) programs.

UF Innovate Names New Director of Incubation Services

UF Innovate is pleased to welcome Karl R. LaPan as the incoming director of incubation services. He will join the team May 3 and work alongside current Director Mark S. Long, who will retire this summer. LaPan comes to the position with more than 20 years of experience in business incubation.